Banca de DEFESA: THAYS SANTOS MENDONCA

Uma banca de DEFESA de DOUTORADO foi cadastrada pelo programa.
STUDENT : THAYS SANTOS MENDONCA
DATE: 07/05/2021
TIME: 09:00
LOCAL: Videoconferência
TITLE:

CLINICAL IMPACT OF FOLLOW-UP PHARMACOTHERAPEUTIC IN PATIENTS WITH TYPE I MELLITUS DIABETES SERVED VIA JUDICIAL

KEY WORDS:

Pharmaceutical care; Type I diabetes mellitus; Insulin; Judicialization

PAGES: 203
BIG AREA: Ciências da Saúde
AREA: Saúde Coletiva
SUMMARY:

Introduction: Brazilian studies show that among the drugs most used by judicial litigation in Brazil, are those used for the treatment of Diabetes Mellitus (DM). In view of this, it is essential to seek strategies that enable the improvement of patient care management, in an efficient and resolutive manner. Objectives: To evaluate the use of public health services, compliance with clinical protocols and therapeutic guidelines (PCDT), glycemic control and the effectiveness of pharmacotherapeutic follow-up in patients with type 1 Diabetes Mellitus (T1DM) who receive at least one drug through judicial litigation. Methods: The study population corresponded to patients with T1DM who receive at least one drug through judicial litigation in the municipality of Divinópolis-MG. Studies with secondary data were carried out to verify if the patients were monitored by the Unified Health System (SUS) and if they had previously used human insulins (compliance with the PCDT). Through a crosssectional study, the glycemic control of patients was verified by means of tests of fasting glycemia and glycated hemoglobin and a single arm intervention study was carried out by means of pharmacotherapeutic follow-up in these patients. Results: 55.1% of patients are not monitored by SUS, 53.9% did not use human insulin prior to the use of analogs, 90% did not have glycemic control and pharmacotherapeutic follow-up promoted improvements in blood glucose, blood pressure levels, knowledge about the insulin application techniques, quality of life and health, eating habits and resolution of Pharmacotherapeutic Problems. Conclusion: Most patients with T1DM who receive drugs by judicial means in the analyzed municipality are not monitored by SUS, did not present compliance with the PCDT and did not have glycemic control. However, pharmacotherapeutic follow-up has provided clinical, therapeutic, laboratory and behavioral benefits, with an improvement in the quality of life and health of these patients

BANKING MEMBERS:
Externa à Instituição - DJENANE RAMALHO DE OLIVEIRA - UFMG
Presidente - 1039964 - ANDRE DE OLIVEIRA BALDONI
Externo à Instituição - GENIVAL ARAÚJO DOS SANTOS JÚNIOR - UFES
Externo à Instituição - LEONARDO RÉGIS LEIRA PEREIRA - USP
Externo à Instituição - MÁRCIO EDUARDO SENRA NOGUEIRA - UIT
Externo à Instituição - TIAGO MARQUES DOS REIS - UNIFAL-MG